Outcome Capital has won honors as the Top Life Sciences Advisory & Investment Banking Firm – 2024 per Life Sciences Magazine January 2024 Read the full article from Life Science Magazine here: Read More
Read MoreOutcome Capital Life Science Market Pulse March 2024 Click to view our LifeSciences Pulse Newsletter
DownloadJune 17, 2021 09:40 AM Eastern Daylight Time BOSTON, MA–(BUSINESS WIRE)–Outcome Capital, a specialized advisory and investment banking firm that serves middle market companies in...
Read MoreBOSTON, MA & RESTON, Va.–(BUSINESS WIRE)–Outcome Capital (www.outcomecapital.com) today announced that Steven Wardell and Karl Hess have joined the firm as Senior Advisors for its...
Read MoreRESTON, Va.–(BUSINESS WIRE)–Outcome Capital, an advisory and investment banking firm that serves middle market growth companies in IT services, software, managed services, ADGS, healthcare and...
Read MoreThe Contract Waterfall: Important Financial Tool in a Federal Government Contractor’s Toolset The contract waterfall plays an important role for both the buyer and the...
Read MoreOutcome Capital Advises Forward Photonics in its Sale April 24, 2020, Reston, VA Outcome Capital, an investment banking firm that serves middle market growth...
Read MoreOutcome Capital Secures Growth Capital for Whisker Labs November 26, 2019, Reston, VA Outcome Capital, an investment banking firm that serves middle market growth companies...
Read MoreOutcome Capital and Partners HealthCare Innovation Collaborate through the Innovation Fellows Program to Provide Experience in the Business of Science June 4, 2019, Boston, MA...
Read MoreOutcome Capital Advises Whisker Labs in the Sale of its Energy Management Business to Resideo Technologies May 29, 2019, Reston, VA Outcome Capital, an investment...
Read MoreOutcome Capital Announces Meridian Bioscience Has Acquired GenePOC May 1, 2019, BOSTON, MA –(BUSINESS WIRE)– Outcome Capital, a specialized investment banking firm that serves middle...
Read MoreFederal Data Systems Has Received an Investment from McNally Capital August 30, 2018, Reston, VA Federal Data Systems, Inc (FedData) has received an investment from...
Read MoreOutcome Capital Announces Digital Intelligence Systems Has Acquired Xtreme Consulting Group June 18, 2018, Reston, VA and Boston, MA. Outcome Capital, an investment banking firm that...
Read MoreJune 1, 2018, Reston, VA & Boston, MA. Outcome Capital (outcomecapital.com), a 20-year-old investment banking boutique that serves the middle market in the technology and...
Read MoreOutcome Capital Announces ATPCO Has Acquired Routehappy February 26, 2018, Reston, VA and Boston, MA. Outcome Capital, an investment banking firm that serves middle market...
Read MoreOutcome Capital looks forward to attending JP Morgan’s Annual Healthcare Conference in January 2018. If you are interested in meeting to discuss your...
Read MorePlenary Session: Different Approaches VCs Take When Investing in Companies Tuesday, October 24th 2:30 PM – 3:30 PM Location: Grand Ballroom—Salons 1 & 2 (7th...
Read MoreBuilding an Amazing Organization with the Strength of the Right Financial Partners Oded Ben-Joseph, PhD. from Outcome Capital is pleased to take part as...
Read MoreOutcome Capital and Boston University’s BEST Program Partner to Give Scientists Real-Life Experience in the Life Science Sector June 21, 2017, Boston, MA. Outcome Capital,...
Read MoreOutcome Capital Announces UCB Pharma Has Acquired Beryllium Discovery June 6, 2017, Boston, MA. Outcome Capital, an investment banking firm that serves middle market growth...
Read MoreOutcome Capital Congratulates ColonaryConcepts on Sale of Colon Preparation Business Unit to Sebela Pharmaceuticals June 1, 2017, Boston, MA. Outcome Capital (outcomecapital.wpengine.com), a highly specialized investment...
Read MoreDr. Baron’s Extensive Life Science Investment Experience and Deep Knowledge of Emerging Growth Pharma and Biotech Markets Will Bolster Outcome’s Client Service Offerings January 24,...
Read MoreWould you like to learn more about working with Outcome Capital or discuss your specific needs?